In the past weeks, the decision of the European Court of Justice regarding the reduction of the VAT assessment base for compulsory manufacturer discounts in the pharmaceutical industry (ECJ, decision dated 20.12.2017 – C-462/16 / Boehringer Ingelheim Pharma GmbH & Co. KG) and its practical consequences in the national and international context were intensively discussed in the industry and trade press.
I would like to invite you to our web based “ITX Pharma Virtual Round Table” to discuss this topic together with other tax specialists of the pharmaceutical industry and international ITX experts of PwC in this area, who are dedicated to the pharmaceutical industry. During our web based Virtual Round Table we will give you an overview of possible impacts of this ECJ decision within different EU member states. You will have the opportunity to exchange your experiences and views on the issue with other international leaders.
Please click HERE to register for the event.
I do hope that you can join us!
Bildquelle: Tim Reckmann / pixelio.de